Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-05

FDA Approved: ORAVIG — Supplemental Application (Galt Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for ORAVIG (miconazole) submitted by Galt Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORAVIG (MICONAZOLE)

Snippet

SUPPL AP for ORAVIG (MICONAZOLE)